DSC
MAIA icon

Daytona Street Capital’s MAIA Biotechnology MAIA Stock Holding History

Daytona Street Capital’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.8K Hold
7,500
– – 0.01% 237
2026
Q1 		$10.4K Hold
7,500
– – 0.01% 249
2025
Q4 		$11.5K Buy
+7,500
New +$9.79K 0.01% 258

Other funds holding MAIA

CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Daytona Street Capital's MAIA Position: Q2 2026 in Review

Daytona Street Capital held its MAIA Biotechnology (MAIA) position steady in Q2 2026 at 7,500 shares worth $10.8K. The position accounts for 0.01% of the portfolio, ranked #237.

Daytona Street Capital first reported a position in MAIA in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.5K in Q4 2025. 11 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Daytona Street Capital held 7,500 shares of MAIA Biotechnology worth $10.8K as of Q2 2026.
  • Daytona Street Capital left its MAIA Biotechnology share count unchanged in Q2 2026.
  • MAIA Biotechnology made up 0.01% of Daytona Street Capital's portfolio in Q2 2026, its #237 holding.
  • Daytona Street Capital first reported a position in MAIA Biotechnology in Q4 2025 and has held it in 3 quarters since.
  • Daytona Street Capital's MAIA Biotechnology position peaked at $11.5K in Q4 2025.
  • 11 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Daytona Street Capital's 13F filing for Q2 2026, filed 3 Aug 2026.